Advances in Oncology, 2024

— —

Leonidas C. Platanias (Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics, USA)

Advances in Oncology, 2024

Leonidas C. Platanias (Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics, USA)

$328

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Churchill Livingstone
28 May 2024

Oncology; Haematology; Surgical oncology

Series: Advances

Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.

Contains 26 articles on such topics as management of locoregional melanoma; surgery for recurrent ovarian cancer; advances in pediatric cancer with big data: the Pediatric Cancer Data Commons; advanced imaging in gliomas; approach to minimal residual disease for acute myeloid leukemia; treatment options for HER2-expressing gastroesophageal cancers; and more. Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice. Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

Edited by: Leonidas C. Platanias (Director Robert H. Lurie Comprehensive Cancer Center Northwestern University Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics USA)
Imprint: Churchill Livingstone
Country of Publication: United Kingdom
Dimensions: Height: 235mm, Width: 191mm,
Weight: 450g
ISBN: 9780443247002
ISBN 10: 0443247005
Series: Advances
Pages: 240
Publication Date: 28 May 2024
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Contemporary Management of Dermatofibrosarcoma Protuberans Management of Locoregional Melanoma Current Management of Intraductal Papillary Mucinous Neoplasms Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy Optimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung Cancer Beyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to Resistance Antibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application Surgery for Recurrent Ovarian Cancer Big Data in Pediatric Oncology: Hope, Hype, Reality Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas Diagnostic and Theranostic Opportunities in Neuro-Oncology Updates on Revised Diagnostic Criteria and Targeted Therapies for Neurofibromatosis Management of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell Transplantation T-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth Watching Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia Role of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial Cancer Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Patient Selection and Overview of Doublet and Triplet Therapy Data Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers Current and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal Cancers Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma